ZANGRILLI, ARIANNA
 Distribuzione geografica
Continente #
NA - Nord America 5.470
EU - Europa 468
AS - Asia 304
OC - Oceania 4
SA - Sud America 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.252
Nazione #
US - Stati Uniti d'America 5.465
SG - Singapore 147
CN - Cina 102
IE - Irlanda 90
DE - Germania 77
SE - Svezia 67
IT - Italia 59
UA - Ucraina 52
FR - Francia 36
GB - Regno Unito 33
RU - Federazione Russa 31
KR - Corea 17
UZ - Uzbekistan 13
FI - Finlandia 11
IN - India 8
KG - Kirghizistan 7
AU - Australia 4
CA - Canada 4
BE - Belgio 3
HK - Hong Kong 3
RO - Romania 3
BR - Brasile 2
CH - Svizzera 2
EG - Egitto 2
NL - Olanda 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BG - Bulgaria 1
EU - Europa 1
IQ - Iraq 1
IR - Iran 1
JP - Giappone 1
KH - Cambogia 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
TR - Turchia 1
Totale 6.252
Città #
Wilmington 1.600
Houston 1.294
Woodbridge 1.156
Fairfield 240
Chandler 209
Singapore 129
Ashburn 125
Ann Arbor 110
Seattle 97
Cambridge 91
Dublin 85
Medford 64
Dearborn 46
Jacksonville 43
Lawrence 30
Beijing 28
New York 25
Santa Clara 23
San Diego 18
Zhengzhou 18
Moscow 12
Rome 12
Shanghai 11
Boardman 10
Munich 9
Hefei 8
Seoul 8
Menlo Park 7
Norwalk 7
Redmond 7
Redwood City 7
Esslingen am Neckar 5
Jinan 4
Kilburn 4
Nanjing 4
Palo Alto 4
Sedico 4
Sydney 4
Augusta 3
Brussels 3
Detroit 3
Genazzano 3
London 3
Mülheim 3
Nanchang 3
Paris 3
Aprilia 2
Atlanta 2
Bari 2
Bologna 2
Cairo 2
Central 2
Coimbatore 2
Falls Church 2
Fuzhou 2
Giugliano In Campania 2
Guidonia 2
Hebei 2
Joliet 2
Kunming 2
Milan 2
Nürnberg 2
Pune 2
Saint Petersburg 2
San Francisco 2
Shenyang 2
Stockertown 2
Stockport 2
Suceava 2
Sundern 2
Toronto 2
Wuhan 2
Acton 1
Albano Laziale 1
Ankara 1
Ardabil 1
Auburn Hills 1
Bellingham 1
Boston 1
Büdelsdorf 1
Chengdu 1
Chicago 1
Chisinau 1
Clearwater 1
Dubai 1
Grezzago 1
Groningen 1
Guadalajara 1
Guangzhou 1
Hangzhou 1
Helsinki 1
Hounslow 1
Kuala Lumpur 1
Lappeenranta 1
Las Vegas 1
Latina 1
Leawood 1
Mountain View 1
Mussidan 1
Nashville 1
Totale 5.662
Nome #
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study 422
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 392
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 392
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study. 384
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 382
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 356
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 348
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 346
Erysipeloid cutaneous metastasis from bladder carcinoma 340
Long-term treatment of psoriatic patients with adalimumab reduces disease severity and maintains a favorable lipid pattern and a low Atherogenic Index. 314
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 298
Radiologically significant joint improvement in a patient affected by psoriatic arthritis treated with adalimumab 280
Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice 227
Paradoxical case effects of psoriasis following adalimumab therapy: A case series 221
Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation 209
One drug and two diseases: A case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast 209
Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation 152
Real life experience of apremilast in psoriasis and arthritis psoriatic patients: preliminary results on metabolic biomarkers 152
Efficacy and safety of Adalimumab in difficult-to-treat psoriasis 146
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations 116
Ixekizumab: One drug for an enigmatic psoriasis 98
Psoriasis in difficult to treat areas: treatment role in improving health-related quality of life and perception of the disease stigma 92
Omalizumab and adalimumab: a winning couple 89
A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic 88
A linear forehead lesion caused by intralesional injection of triamcinolone acetonide and treated with hyaluronic acid filler: case report 77
Adalimumab for moderate to severe psoriasis: an open-label, retrospective 3-year study 66
Risankizumab: How to choose the right dose in clinical practice? 65
Paradoxical psoriasis induced by anti-TNFα treatment: evaluation of disease-specific clinical and genetic markers 59
Long-term efficacy of adalimumab in generalized pustular psoriasis 56
Clinical severity instruments 49
Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: A 52-week Italian real-life experience 11
Totale 6.436
Categoria #
all - tutte 15.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.855


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.351 0 0 0 139 156 188 169 143 127 188 113 128
2020/20211.433 108 124 116 155 223 200 183 169 45 46 37 27
2021/2022340 17 31 21 26 10 20 18 13 19 51 20 94
2022/2023474 37 53 24 56 41 101 38 27 51 13 18 15
2023/2024145 16 3 8 5 19 29 12 23 4 2 0 24
2024/2025249 29 123 96 1 0 0 0 0 0 0 0 0
Totale 6.436